Funding, Free Speech, and Academic Influence

The Trump administration is investigating semiconductors and pharmaceutical ingredients, the first steps toward tariffs in those industries. Former FDA Commissioner and board member at Pfizer and Illumina Dr. Scott Gottlieb shares his concern that if costs get any higher for generics like heparin, hydrocortisone, and amoxicillin, drugmakers might stop manufacturing them. Dr. Gottlieb explains America’s pharma supply chain through China and India, as well as the thin margins on some of the most commonly used drugs in the United States. The Trump administration ordered a freeze on $2.2B grants to Harvard after the university rejected the White House’s demands for changes, including to DEI programs. The move has sparked another debate about free speech on higher education campuses. Plus, the Chinese government has reportedly ordered Chinese airlines to stop buying Boeing aircraft, and DOGE cuts in DC have hit the workforce in Virginia. Governor Glenn Youngkin (R-VA) is still optimistic about his state’s future. 

Glenn Youngkin - 21:21

Dr. Scott Gottlieb - 39:36

In this episode:

Glenn Youngkin, @GovernorVA

Dr. Scott Gottlieb, @ScottGottliebMD

Kelly Evans, @KellyCNBC

Joe Kernen, @JoeSquawk

Andrew Ross Sorkin, @andrewrsorkin

Katie Kramer, @Kramer_Katie